Lebanon’s War Traps Cancer Patients Amid Medicine Shortages

Lebanon’s ongoing conflict disrupts critical cancer treatments, sparking a secondary health crisis. Families face unbearable costs and scarce medicine amid war-driven economic collapse, threatening survival of vulnerable patients.

Lebanon’s war reaches beyond battlefields, endangering civilians suffering chronic illnesses. Cancer patients in Beirut’s oncology wards scramble for scarce drugs amid a crumbling healthcare system.

The conflict has crippled Lebanon’s economy, inflating medicine prices and cutting vital supplies. Patients like eight-year-old Hani confront a brutal reality: treatment delays and prohibitive costs.

This health emergency compounds an already volatile national crisis, straining Lebanon’s fragile medical infrastructure. It highlights the broader consequences of war beyond combat zones, revealing a grim humanitarian toll.

Beirut hospitals face shortages of chemotherapy drugs and radiotherapy equipment. Families bear thousands of dollars in treatment costs; government subsidies have evaporated amid fiscal collapse.

Without urgent international aid, Lebanon’s cancer patients face rising mortality. The war’s shadow grows longer, transforming medical battles into a race against time and dwindling resources.